Lecture 15: Cytokine Signals Flashcards

(53 cards)

1
Q

Cytokine signaling function

A

-macrogphages to induce cell migration
-B cell development for Igs
-blood differentiation
-T cell activation
-cell proliferation
-wound healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Expression of cytokines and receptors

A

-highly regulated
-control pro and anti inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Macrophage release of chemokines induces

A

neutrophil migration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neutrophil migration

A

-innate immunity
-infection activates macrophage to release chemokines that recruit cells
-IL-1B, TNF-a, IL-6, CXCL8, IL-12
-all lead to inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cytokines released from macrophages

A

-IL-1B
-TNF-a
-IL-6
-CXCL8
-IL-12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IL-1B and TNF-a

A

-increase blood vessel permeability
-allow cells and fluid to enter infected tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IL-6

A

-induces fat and muscle metabolism
-raise temp in tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CXCL8

A

-recruits neutrophils from blood and guides them to tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

IL-12

A

-recruits/activates NK cells that secrete cytokines that strengthen macrophage response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neutrophil in absence of infection

A

-circulate in blood
-rolling adhesion on selectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

selectin

A

-glycoproteins that weakly bind to sialyl-Lewis X carbs on neutrophills in blood stream
=rolling adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neutrophil recruitment

A
  1. Rolling adhesion
  2. Tight binding
  3. Diapedesis
  4. Migration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ICAM-1

A

-cell-adhesion molecule
-induced by TNFa
-binds LFA-1 on neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tight binding

A

-ICAM-1 initiates binding to LFA-1 integrin on neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diapedesis

A

-after binding LFA-1, neutrophils can cross endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Migration

A

-CXCL8 secreted by macrophages directs neutrophils across endothelium and to the tissue
-moves along gradient of CXCL8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

monocytes (premacrophage)

A

-similar process to neutrophils
-recruited by CCL2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CXCL8 is a chemokine because

A

it promotes movement of various immune cells in a certain direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cytokine Receptor families (excluding chemokine/GPCR)

A

-TNF
-Type I and II cytokine receptors
-IL-1
-IL-17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

TNF receptor family

A

-trimeric cysteine
-TNF-a
-fibronectin domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type I and II families

A

-both have JAK/STAT pathways
-IL-6
-cysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

IL-1 receptor family

23
Q

IL-17 family

A

-IL-17 ligand

24
Q

fibronectin domain

25
TNFa
-membrane anchored or soluble forms -released by lymphocytes and monocytes during infection -target TNFR1 and 2 -fever, apoptosis, inflammation
26
TNFa release
-from lymphocytes and monocytes -along with IL-1, IL-6, interfeon y
27
TNFa receptors
-cys rich domains -TNFR1 and TNFR2
28
TNFR1
-constitutively expressed on most cell types -PRO inflammatory -apoptotic
29
TNFR2
-restricted to endothelial, epithelial, some immune cells -ANTI inflammatory -cell proliferation
30
TNFa signaling pathway
-TNFa binding leads to receptor oligomerization -generates active complex of multiple proteins -activates NF-kB or MAPK pathway -effects often conflict
31
TNFa dysregulation
-alzheimers, depression, IBD
32
Tasonermin
-TNFa itself -immunostimulant to treat some cancers
33
Etanercept
-treat rheumatoid arthritis and psoriarisis -prevent ligand binding to receptor -fusion protein made by recombinant DNA -extracellular TNFR2 fused to Fc region of IgG1 antibody
34
Type I receptors
-common chain for different subfamilies = redundancy -IL-15 and IL-4 y chain -GM-CSF and IL-5 B chain -IL-6 and IL-11 gp130 chain
35
common chain type I
-cytokine binds to a subunit -complex associates with B subunit (cross-react) -signal transduced through B subunit (redundancy)
36
IL-6 and receptor common gp130 and signaling pathways
37
IL-6
-PRO inflammatory -secreted by T cells -important for differentiation of T and B cells
38
IL-6 receptor signaling
-forms heterohexameric complex : (IL-6, gp130, IL-6Ra) x2 -common gp130 chain response activates PI3K, JAK, MAPK -stimulates accute phase protein synthesis, survival, production of neutrophils, regulates inflammation
39
Heterohexameric complex
-association of IL-6 with IL-6Ra -then with gp130 = trimer -trimer dimerizes
40
JAK/STAT pathway
-type I and II receptors 1. JAK kinase w/ receptor 2. cytokine binding dimerizes receptor = pair of JAK kinases 3. JAK activated, phosphorylzes receptor 4. STAT docks and is phosphorylated 5. pSTAT dissociates and pSTAT dimerizes 6. pSTAT dimer goes to nucleus and mediates transcription of target gene
41
Redundancy from
-common chain -all stimulate B cell proliferation -all trigger JAK/STAT pathway
42
IL-6 dysregulation
-rheumatoid arthritis, sclerosis, lupus, prostate cancer, myeloma
43
IL-6 in cancer
-chronic inflammation -regulation of tumor microenvironments and metastisis
44
Enterovirus 71
-contagious -mild illness -hand/foot/mouth disease -LEADS to ENCEPHALITIS which IL-6 contributes to
45
Drugs against IL-6
-siltuximab -tocilizumab and sailumab
46
siltuximab
-antibody against IL-6 -binds ligand so it cannot get to receptor -treats castleman disease
47
tocilizumab and sarilumab
-Igs against soluble and membrane bound IL-6R -treat rheumatoid arthritis -bind to receptor
48
IL-17
-homodimer and heterodimer of IL-17 A and F -secreted by T cells -thought to be heterotrimer with C
49
IL-17 targets
-macrophages -T cells -endothelial cells -fibroblasts
50
IL-17 signaling pathway
-ACT 1 association with receptor and kinases -increase expression of PRO inflammatory cytokines
51
IL-17 effects
-PRO inflammatory -good vs bacteria and fungus
52
IL-17 overexpression
-asthma -COPD -dampens anti-tumor immunity
53
Secukinumab
Ig against IL-17A -treat psoriaisis